AMP protein kinase activators (Makoto)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameAMP protein kinase activators (Makoto)
Drug Alias NameAMP protein kinase activators (Mercury Therapeutics)AMPK activators (Mercury Therapeutics)AMPK activators (Makoto)MT-201 (Mercury)MT-201-2 +[8] 
ClassificationSmall molecules
Mechanisms of ActionAMP-activated protein kinases modulators
TargetsAMP-activated protein kinases
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAventis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMakoto Life Sciences IncMercury Therapeutics IncAventis
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A